VEGFR2/KDR/Flk-1 Antibody, Novus Biologicals™

VEGFR2/KDR/Flk-1

Polyclonal

Unconjugated

Tris-Glycine, 0.15 M NaCl with 0.05% Sodium Azide

KDR

A synthetic peptide made to a C-terminal region of the mouse VEGF Receptor 2 protein (between residues 1300-1367). [Swiss-Prot# P35918]

Affinity Purified

RUO

Primary

Human and mouse. Predicted to react with rat based on 100% sequence homology.

Store at 4C. Do not freeze.

Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence

2.55 mg/mL

Western Blot 1:250-1:1000, Flow Cytometry reported in scientific literature (PMID 29873146), Immunohistochemistry reported in scientific literature (PMID 30941660), Immunocytochemistry/Immunofluorescence 1:50 - 1:500

CD309, CD309 antigen, EC 2.7.10, EC 2.7.10.1, Fetal liver kinase 1, fetal liver kinase-1, FLK-1, FLK1tyrosine kinase growth factor receptor, Kinase insert domain receptor, kinase insert domain receptor (a type III receptor tyrosine kinase), Protein-tyrosine kinase receptor flk-1, soluble VEGFR2, vascular endothelial growth factor receptor 2, VEGFR, VEGFR2, VEGFR-2

Rabbit

150 kDa

0.025 mL

Angiogenesis, Cancer, Cellular Markers, Endothelial Cell Markers, Hematopoietic Stem Cell Markers, HIF Target Genes, Hypoxia, Signal Transduction, Stem Cell Markers, Tumor Suppressors, Tyrosine Kinases

3791

Human, Mouse, Rat

IgG